JP2015523346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523346A5 JP2015523346A5 JP2015516261A JP2015516261A JP2015523346A5 JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5 JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- neutropenia
- retinoid agonist
- pharmaceutical composition
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261656815P | 2012-06-07 | 2012-06-07 | |
| US61/656,815 | 2012-06-07 | ||
| PCT/US2013/044828 WO2013185105A1 (en) | 2012-06-07 | 2013-06-07 | Methods for treating neutropenia using retinoid agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015523346A JP2015523346A (ja) | 2015-08-13 |
| JP2015523346A5 true JP2015523346A5 (https=) | 2016-06-16 |
| JP6295249B2 JP6295249B2 (ja) | 2018-03-14 |
Family
ID=49712715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516261A Expired - Fee Related JP6295249B2 (ja) | 2012-06-07 | 2013-06-07 | レチノイドアゴニストを用いた好中球減少症の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11116738B2 (https=) |
| EP (1) | EP2858636B1 (https=) |
| JP (1) | JP6295249B2 (https=) |
| KR (1) | KR102083046B1 (https=) |
| CN (1) | CN104519879B (https=) |
| AU (1) | AU2013270674B2 (https=) |
| BR (1) | BR112014030279A2 (https=) |
| CA (1) | CA2874850A1 (https=) |
| ES (1) | ES2691493T3 (https=) |
| MX (1) | MX365321B (https=) |
| NZ (1) | NZ702415A (https=) |
| RU (1) | RU2650962C2 (https=) |
| WO (1) | WO2013185105A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102083046B1 (ko) | 2012-06-07 | 2020-02-28 | 칠드런＇스 하스피틀 로스 앤젤레스 | 레티노이드 작용제를 이용하여 호중구감소증을 치료하기 위한 방법 |
| EP2969031A4 (en) | 2013-03-15 | 2017-03-08 | Avisenna Cosmetics LLC | Topical compositions for reducing aging effects |
| MX2016010699A (es) * | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
| PL3277272T3 (pl) | 2015-03-31 | 2022-01-24 | Syros Pharmaceuticals, Inc. | Sposoby stratyfikacji pacjentów do leczenia agonistami receptora kwasu retinowego |
| US9868994B2 (en) | 2016-04-08 | 2018-01-16 | Syros Pharmaceuticals, Inc. | Methods of stratifying patients for treatment with retinoic acid receptor-α agonists |
| WO2018067946A1 (en) * | 2016-10-06 | 2018-04-12 | Syros Pharmaceuticals, Inc. | Methods of treating patients with a retinoic acid receptor-alpha agonist and an anti-cd38 antibody |
| EP3743722A4 (en) * | 2018-01-26 | 2022-03-02 | Agency for Science, Technology and Research | NEUTROPHIL SUBTYPES |
| CN113969261B (zh) * | 2020-07-06 | 2024-04-09 | 苏州市立医院(北区) | 三步法快速测定中性粒细胞趋化的方法 |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
| FI131561B1 (en) * | 2023-12-28 | 2025-06-30 | Faron Pharmaceuticals Oy | CLEVER-1 INHIBITOR TO PROMOTE HEMATOLOGICAL RECOVERY WHEN USING CHEMOTHERAPY |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691196A (en) * | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| EP0957918A1 (en) * | 1996-12-19 | 1999-11-24 | American Cyanamid Company | Method of treating or inhibiting neutropenia |
| MXPA03002045A (es) | 2000-09-08 | 2003-07-24 | Amgen Inc | Composiciones analogas de factor estimulador de colonias de granulocitos y metodos para su elaboracion. |
| US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| KR20060018851A (ko) | 2003-05-16 | 2006-03-02 | 교와 핫꼬 고교 가부시끼가이샤 | 조직 파괴를 수반하는 질환의 예방 및/또는 치료제 |
| EP1621191A1 (en) * | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
| JP2008509928A (ja) * | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆／幹細胞を動員するためのケモカインの組み合わせ |
| ATE476981T1 (de) | 2004-12-02 | 2010-08-15 | Venus Remedies Ltd | Zusammensetzungen zur bekämpfung von beta- lactamase-vermittelter antibiotischer resistenz mittels beta-lactamase-hemmern für injektionen |
| US20090111786A1 (en) * | 2004-12-03 | 2009-04-30 | Glass Christopher K | Compounds that Prevent Macrophage Apoptosis and Uses Thereof |
| TR201819157T4 (tr) * | 2006-05-16 | 2019-01-21 | Io Therapeutics Llc | Kemoterapi Ve Veya Radyasyon Terapisinin Yan Etkilerinin Tedavisinde Kullanıma Yönelik Rar Antagonisti Veya Ters Agonisti |
| EP2143428B1 (en) * | 2007-03-30 | 2015-11-04 | TMRC Co., Ltd. | Tamibarotene capsule preparation |
| WO2009070844A1 (en) * | 2007-12-06 | 2009-06-11 | Csl Limited | Method of inhibition of leukemic stem cells |
| US8580516B2 (en) | 2008-09-05 | 2013-11-12 | University Of Chicago | Methods and compositions for direct detection of DNA damage |
| CN102612371B (zh) | 2009-10-19 | 2014-03-19 | 莱拉营养食品有限公司 | 含有多聚乙酰的提取物，分馏物和混合物及它们的应用 |
| RU2446173C1 (ru) | 2010-08-13 | 2012-03-27 | Зао "Биокад" | Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе |
| CN102380090A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| CA2826386C (en) | 2011-02-08 | 2020-04-28 | FUJIFILM Cellular Dynamics, Inc. | Hematopoietic precursor cell production by programming |
| JP6242868B2 (ja) * | 2012-05-08 | 2017-12-06 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγのアゴニストとしての使用のためおよび疾患の処置のためのテトラヒドロ［１，８］ナフチリジンスルホンアミドおよび関連化合物 |
| KR102083046B1 (ko) | 2012-06-07 | 2020-02-28 | 칠드런＇스 하스피틀 로스 앤젤레스 | 레티노이드 작용제를 이용하여 호중구감소증을 치료하기 위한 방법 |
| DE102012011766B3 (de) | 2012-06-15 | 2013-12-19 | Voith Patent Gmbh | Getriebeeinheit |
| CN110946993A (zh) | 2014-01-03 | 2020-04-03 | 上海泽生科技开发股份有限公司 | 纽兰格林制剂的配方 |
| MX2016010699A (es) | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
-
2013
- 2013-06-07 KR KR1020157000014A patent/KR102083046B1/ko not_active Expired - Fee Related
- 2013-06-07 RU RU2014153988A patent/RU2650962C2/ru not_active IP Right Cessation
- 2013-06-07 BR BR112014030279A patent/BR112014030279A2/pt not_active Application Discontinuation
- 2013-06-07 JP JP2015516261A patent/JP6295249B2/ja not_active Expired - Fee Related
- 2013-06-07 WO PCT/US2013/044828 patent/WO2013185105A1/en not_active Ceased
- 2013-06-07 AU AU2013270674A patent/AU2013270674B2/en not_active Ceased
- 2013-06-07 CN CN201380041537.6A patent/CN104519879B/zh not_active Expired - Fee Related
- 2013-06-07 MX MX2014014930A patent/MX365321B/es active IP Right Grant
- 2013-06-07 US US14/405,141 patent/US11116738B2/en active Active
- 2013-06-07 EP EP13800873.5A patent/EP2858636B1/en not_active Not-in-force
- 2013-06-07 ES ES13800873.5T patent/ES2691493T3/es active Active
- 2013-06-07 NZ NZ702415A patent/NZ702415A/en not_active IP Right Cessation
- 2013-06-07 CA CA2874850A patent/CA2874850A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015523346A5 (https=) | ||
| JP2013533858A5 (https=) | ||
| JP2019519519A5 (https=) | ||
| JP2016535786A5 (https=) | ||
| JP2014510729A5 (https=) | ||
| JP2012046518A5 (https=) | ||
| JP2017512193A5 (https=) | ||
| JP2012121878A5 (https=) | ||
| RU2014153988A (ru) | Способы лечения нейтропении с применением ретиноидных агонистов | |
| JP2009298801A5 (https=) | ||
| MA38144A1 (fr) | Compositions et procédés pour le traitement de protéinopathies | |
| JP2012144574A5 (https=) | ||
| UA118255C2 (uk) | Композиція, яка містить антитіло до cd38 і леналідомід | |
| JP2011157378A5 (https=) | ||
| JP2012180381A5 (https=) | ||
| JP2010285439A5 (https=) | ||
| JP2018505882A5 (https=) | ||
| JP2012522010A5 (https=) | ||
| JP2016516074A5 (https=) | ||
| Chen et al. | Control of methicillin-resistant Staphylococcus aureus pneumonia utilizing TLR2 agonist Pam3CSK4 | |
| BR112014027010A2 (pt) | uso de laquinimod de alta dose para tratamento de esclerose múltipla | |
| JP2015511625A5 (https=) | ||
| Li et al. | Cecropin AD ameliorates pneumonia and intestinal injury in mice with mycoplasma pneumoniae by mediating gut microbiota | |
| JP2008154589A5 (https=) | ||
| JP2017527615A5 (https=) |